Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of physical training, Aspirin, and Clopidogrel on walking capacity in stage II peripheral arterial disease
2004-005041-35Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel and Cartia in arteriosclerosis obliterans and intermittent claudication (IC) (2 arms), sponsored by University Hospital Basel. Primary endpoint: Change in initial claudication distance (ICD). Started May 2006; status: completed.
02
Drugs
clopidogrelCartia
03
Conditions
arteriosclerosis obliteransintermittent claudication (IC)
Beyond the preview
Go deeper on 2004-005041-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005041-35.